Position in TEVA
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$53,182,461
-$47,598,560 QoQ
Shares Held
1,765,686
-45.3% QoQ
Ownership
0.152%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Amundi holds $607,665,967 across 23 Drug Manufacturers - Specialty & Generic names. TEVA ranks #3 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,166,361 | $374,295,531 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
147,599 | $87,523,254 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
1,765,686 | $53,182,461 | |
| 4 | VTRS |
Viatris Inc
|
3,407,023 | $46,028,880 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
203,637 | $26,827,137 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
78,456 | $5,950,886 | |
| 7 | HCM |
HUTCHMED (China) Ltd
|
232,246 | $3,474,399 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
98,313 | $2,352,630 |
All Filings in TEVA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $53,182,461 | 1,765,686 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $100,781,021 | 3,229,126 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $24,587,681 | 1,217,212 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $22,180,569 | 1,323,423 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $10,432,508 | 678,758 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $12,626,978 | 572,912 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $11,782,736 | 653,870 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $10,636,778 | 654,571 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,626,044 | 540,471 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,540,282 | 434,893 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $5,259,149 | 515,603 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,835,200 | 509,323 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,990,402 | 450,893 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,742,354 | 410,346 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,169,862 | 392,796 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,320,023 | 308,514 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $2,886,682 | 307,421 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,040,072 | 254,691 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,425,522 | 249,027 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,556,000 | 258,182 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||